- Pacira Pharmaceuticals (NASDAQ:PCRX): Q3 EPS of $0.20 beats by $0.22.
- Revenue of $68.36M (+9.9% Y/Y) beats by $1.2M.
- Press Release
Pacira Pharmaceuticals beats by $0.22, beats on revenue
Recommended For You
More Trending News
About PCRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| PCRX | - | - |
| Pacira BioSciences, Inc. | ||